Evaluation of the efficacy of oral agar gel administration on prevention of non hemolytic jaundice in normal term neonates; a double blind controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138811133250N1

Enrollment

Registered

2010-04-24

Start date

2009-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal jaundice, unspecified

Interventions

Intervention 1: Oral prescription of solution of 500 miligram of oral agar gel in 2.5 mililiter aquapura every 6 hours for 3 days. Intervention 2: Oral prescription of 2.5 mililiter of aquapura every

Prevention

Placebo

Oral prescription of solution of 500 miligram of oral agar gel in 2.5 mililiter aquapura every 6 hours for 3 days

Oral prescription of 2.5 mililiter of aquapura every 6 hours for 3 days

Eligibility

Sex/Gender

All

Age

No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: healthy, term infant with birth weight more than 2500 grams Exclusion criteria: Infants with infection, ABO or Rh incompatibility, G6PD deficiency and signs of lethargy or poor feeding

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum bilirubin level. Timepoint: First day of life, third and 5th days of life after intervention. Method of measurement: JM103- skin jaundicometer.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026